Intellia Therapeutics, Inc. (NTLA) Stock Price & Analysis
Market: NASDAQ • Sector: Healthcare • Industry: Biotechnology
Intellia Therapeutics, Inc. (NTLA) Profile & Business Summary
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline includes NTLA-5001 for the treatment of acute myeloid leukemia; and proprietary programs focused on developing engineered cell therapies to treat various oncological and autoimmune disorders. In addition, it offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. Intellia Therapeutics, Inc. has license and collaboration agreements with Novartis Institutes for BioMedical Research, Inc. to engineer hematopoietic stem cells for the treatment of sickle cell disease; Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; Ospedale San Raffaele; and a strategic collaboration with SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases. The company was formerly known as AZRN, Inc. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Key Information
| Ticker | NTLA |
|---|---|
| Exchange | NASDAQ |
| Official Site | https://www.intelliatx.com |
Market Trend Overview for NTLA
One model, two time views: what the market looks like right now, and where the larger trend is heading over time.
SRE (WhaleQuant Structural Regime Engine) SRE evaluates how price structure evolves across daily and weekly timeframes to define the prevailing market regime. Beyond identifying trends, consolidations, and exhaustion phases, it distinguishes between raw structural strength and deployable participation quality. The model dynamically adjusts for structural context and extension risk, assessing whether conditions are supportive, stretched, fragile, or structurally impaired. Its purpose is not to forecast precise price levels, but to determine whether risk deployment is aligned with underlying market structure.
Longer-Term Market Trend (Mid to Long Term)
Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-09-24 (ET)
As of 2026-09-24, NTLA is moving sideways with low volatility. Over the longer term, the trend remains bullish.
NTLA last closed at 12.16. The price is about 0.3 ATR above its recent average price (11.82), and the market is currently in a sideways market with low volatility. Price at 12.16 is moving between light support near 11.81 and light resistance near 12.87. Direction remains unclear. View Support & Resistance from Options
Price is moving in a tight range. This often leads to a stronger move once the range breaks, increasing one-sided risk.
Trend score: 40 out of 100. Overall alignment is unclear. The market is currently in a sideways phase with tightening price movement. The longer-term trend is still positive, but short-term signals are not yet confirming it.
A key downside risk boundary is near 11.26. If price falls below this area, the current structure would likely weaken further.
On 2026-09-10, trend conditions deteriorated, suggesting that moves in the prior direction became less dependable.
[2026-09-14] Price moved quickly and looked strong, but participation was limited.
Recent bars show mixed price behavior without a clear shift in structural quality or efficiency.
Some late-day positioning was observed, but it lacked strong overnight commitment.
The model stays neutral because the setup is not clear enough to justify a directional deployment.
The model does not deploy this setup because price is still close to a gamma transition zone. Predictability is 36%, agreement is 71%, and reversal risk is 21%.
NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history
This estimate uses 1-minute price, volume, and VWAP data from the last 45 trading days, with turnover-based decay. The sample period is 2026-07-23 to 2026-09-24. The current price is 12.16, 0.46% above the estimated average cost of 12.10. An estimated 49.5% of recent positioning is below the current price, while 50.0% is above it. The peak-density price is 12.73. The largest concentrated cost region is 11.69 to 12.87 and contains 64.9% of the estimated distribution. The current price is within the 11.69 to 12.87 cost region. The nearest region below the current price is 11.64 to 11.67. The nearest region above the current price is 13.13 to 13.16.
Short Interest & Covering Risk for NTLA
This analysis looks at overall short interest positioning, focusing on the broader setup rather than short-term noise.
Shows how likely a short squeeze may be under current market conditions.
Short Exposure Percentile
Short interest is relatively low, indicating limited pressure from short positions. (Historical percentile: 6%)
Structure Analysis
NTLA Short positioning is starting to look crowded. Current days to cover is 12.9 trading days, meaning short positions would unwind somewhat slower than average. Short covering could add extra momentum to price moves. Price is already trending lower (20D return -7.8%). The current configuration reflects active downside pressure rather than latent structural fragility.
Risk Summary
Some early warning signs are emerging. Price strength remains intact, but underlying support may be starting to weaken.This indicator is intended as a risk filter, not a directional signal. A High or Extreme reading does not predict an immediate move, but suggests that if prices weaken, downside reactions may be more pronounced.
Why Price Reactions May Be Stronger?
Short positioning is elevated both relative to its own history and in absolute short-interest terms. Average trading volume is weakening, indicating contracting liquidity. Phase: Building. Adaptive thresholds applied to liquidity weakness, near-high detection, and compression sensitivity. Crowded short positioning and weakening liquidity are reinforcing each other. As a result, similar news or market events could lead to price moves about 2× larger than usual.
Note:
Short interest data is reported every two weeks by
FINRA.
The most recent snapshot is
2026-08-31 (ET).
Because this data updates slowly, it is not intended to predict short-term price moves. Instead, it helps describe longer-term market structure and where pressure may be building if prices begin to move.